Literature DB >> 15703411

Presenilin-1-dependent transcriptome changes.

Károly Mirnics1, Zeljka Korade, Dominique Arion, Orly Lazarov, Travis Unger, Melissa Macioce, Michael Sabatini, David Terrano, Katherine C Douglass, Nina F Schor, Sangram S Sisodia.   

Abstract

Familial forms of Alzheimer's disease (FADs) are caused by the expression of mutant presenilin 1 (PS1) or presenilin 2. Using DNA microarrays, we explored the brain transcription profiles of mice with conditional knock-out of PS1 (cKO PS1) in the forebrain. In parallel, we performed a transcription profiling of the hippocampus and frontal cortex of the FAD-linked DeltaE9 mutant transgenic (TG) mice and matched controls [TG mice expressing wild-type human PS1 (hPS1)]. When the TG and cKO datasets were cross-compared, the majority of the 30 common expression alterations were in opposite direction, suggesting that the FAD-linked PS1 variant produces transcriptome changes primarily by gain of aberrant function. Our microarray studies also revealed an unanticipated inverse correlation of transcript levels between the brains of mice that coexpress DeltaE9 hPS1+ amyloid precursor protein (APP)695 Swe and DeltaE9 hPS1 single transgenic mice. The opposite directionality of these changes in transcript levels must be a function of APP and/or APP derivatives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703411      PMCID: PMC6726008          DOI: 10.1523/JNEUROSCI.4145-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

Review 1.  Microarrays and the microscope: balancing throughput with resolution.

Authors:  Giovanni Coppola; Daniel H Geschwind
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Why our patients (and we) need basic science research.

Authors:  Nina F Schor
Journal:  Neurology       Date:  2013-05-28       Impact factor: 9.910

4.  A Life at the Interface: The 2017 Hower Award Lecture.

Authors:  Nina F Schor
Journal:  Pediatr Neurol       Date:  2017-12-07       Impact factor: 3.372

5.  Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor.

Authors:  Tong Zhang; Zhiping Mi; Nina F Schor
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

Review 6.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

7.  Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress.

Authors:  Alliya Qazi; Marc W Halterman; Zhiping Mi; Tong Zhang; Nina F Schor
Journal:  Oxid Med Cell Longev       Date:  2011-09-05       Impact factor: 6.543

8.  Pathological and physiological functions of presenilins.

Authors:  Kulandaivelu S Vetrivel; Yun-wu Zhang; Huaxi Xu; Gopal Thinakaran
Journal:  Mol Neurodegener       Date:  2006-06-12       Impact factor: 14.195

9.  Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice.

Authors:  Károly Mirnics; Eric M Norstrom; Krassimira Garbett; Se Hoon Choi; Xiaoqiong Zhang; Philip Ebert; Sangram S Sisodia
Journal:  Mol Neurodegener       Date:  2008-10-03       Impact factor: 14.195

10.  Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.

Authors:  Véréna Landel; Kévin Baranger; Isabelle Virard; Béatrice Loriod; Michel Khrestchatisky; Santiago Rivera; Philippe Benech; François Féron
Journal:  Mol Neurodegener       Date:  2014-09-11       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.